Latest Posts

02 Nov 2017

CVS Health in acquisition talks with Aetna

The federal government had no sooner busted the proposed merger of Humana and Aetna, than CVS Health began working quietly to acquire Aetna in a $66 billion deal. First, big box drugstore retailers such as CS and Walgreens added primary care services to their businesses awhile ago. They started giving flu

0
Manamed PlasmaFlow photo
02 Nov 2017

FDA approves DVT prevention device

California-based ManaMed has launched the U.S. Food and Drug Administration (FDA) approved deep vein thrombosis (DVT) prevention device PlasmaFlow in the United States. The portable, tubeless and digital PlasmaFlow, which comes with multiple pressure functions, helps to prevent the onset of DVT in patients by revitalizing blood flow in the

0
Reva scaffolding
02 Nov 2017

Reva scaffolding study yields good results

As some companies have worked to improve drug-eluting stents by making them bioresorbable, some voices in the coronary intervention space have expressed concern over the rates of late stent thrombosis and repeat percutaneous coronary intervention seen with the devices. In a study published in a recent issue of JACC: Cardiovascular

0
Medtronic Concerto
02 Nov 2017

Medtronic Concerto 3D Detachable Coil unveiled for vein embolization

Medtronic has unveiled its new Concerto 3D Detachable Coil System that is intended to be used for embolizations in the peripheral arteries and veins. The device was unveiled at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) meeting in Copenhagen, Denmark in September. The device, which is now available to physicians

0
02 Nov 2017

Boston Scientific to distribute Veniti VICI Venous Stent

Veniti Inc., a research company in the advancement of treatment for deep venous disease, has announced that Boston Scientific will distribute its VICI Venous Stent under a limited global distribution agreement. The terms of the agreement and specific regions and countries involved were not disclosed. Physicians treat the obstructive component

0
SHARE

Home